SCHEMBL4074497

SCHEMBL4074497

CC(C#N)(C#N)COCc1ccccc1.CC(O)(C#N)CC#N

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.41
POLB P06746 1/20 0.41
CTSS P25774 4/20 0.38
TSHR P16473 1/20 0.38
SGMS2 Q8NHU3 1/20 0.35
CTSL P07711 2/20 0.34
CTSB P07858 2/20 0.34
CA1 P00915 3/20 0.34
ALDH1A1 P00352 2/20 0.33
TACR1 P25103 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
MAOB P27338 1/20 0.33
GHSR Q92847 2/20 0.32
CHRM3 P20309 1/20 0.32
CA2 P00918 2/20 0.32
CA7 P43166 2/20 0.32
CA9 Q16790 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3338802 0.87 TSHR (0.50) KDM4EPOLBCTSSTSHRSGMS2
SCHEMBL20267540 0.77 TSHR (0.47) KDM4EPOLBCTSSTSHRSGMS2
SCHEMBL5555321 0.75 KDM4E (0.51) KDM4EPOLBCTSSTSHRSGMS2
SCHEMBL3301730 0.74 TSHR (0.50) KDM4EPOLBCTSSTSHRSGMS2
SCHEMBL5560667 0.72 TSHR (0.41) KDM4EPOLBCTSSTSHRSGMS2
SCHEMBL95926 0.71 KDM4E (0.56) KDM4EPOLBTSHRCA1ALDH1A1
SCHEMBL13557891 0.71 KDM4E (0.56) KDM4EPOLBTSHRCA1ALDH1A1
SCHEMBL5529079 0.71 KDM4E (0.53) KDM4EPOLBCTSSTSHRSGMS2
SCHEMBL2477199 0.70 CTSS (0.45) KDM4EPOLBCTSSTSHRCTSL
SCHEMBL6043011 0.69 TSHR (0.58) KDM4EPOLBTSHRCA1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2069310-A2 SULFONYLPYRAZOLINE CARBOXAMIDINE DERIVATIVES AS 5-HT6 ANTAGONISTS Solvay Pharmaceuticals B.V. (NL) 2009-06-17 EP disclosed
WO-2008034863-A2 SULFONYLPYRAZOLINE CARBOXAMIDINE DERIVATIVES AS 5-HT6 ANTAGONISTS SOLVAY PHARMACEUTICALS B.V. (NL) 2008-03-27 WO disclosed